Biotech vet Paul Brennan takes helm at regenerative med biotech; Axcella names CFO

San Diego Biotechnology Network
San Diego Biotechnology Network
Biotech vet Paul Brennan takes helm at regenerative med biotech; Axcella names CFO
Loading
/
Paul Brennan

? Regenerative medicine company, NervGen Pharma ? focused on the treatment of nerve damage ? has tapped Paul Brennan to head the helm of the company as CEO and president. Brennan is the successor to Ernest Wong, who will continue to serve as a consultant to the company. In addition, the company has enlisted Lloyd Mackenzie in the newly created position of COO. Brennan?s previous stints include roles at Eupraxia Pharmaceuticals, Aquinox Pharmaceuticals, Arbutus Biopharma (formerly Tekmira Pharmaceuticals) and AnorMED among others. Brennan played roles in handling th